Form4insider filings, from the source

SEC Form 4 · accession 0001225208-18-010615

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kevin J. Ballinger
Officer — EVP & Pres, Interven Cardio
Period of report
Jun 11, 2018
Accepted (ET)
Jun 13, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jun 11, 2018M37,430$7.39A108,581D
Common StockF2Jun 11, 2018M31,056$7.16A139,637D
Common StockF2Jun 11, 2018S700$36.77D138,937D
Common StockF2Jun 11, 2018S31,056$32.00D107,881D
Common StockF3,F2Jun 11, 2018S36,730$35.8702D71,151D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F4$7.16Jun 11, 2018M31,056D—Feb 28, 2021Common Stock31,0560D
Stock Option (Right to Buy)F5$7.39Jun 11, 2018M37,430D—Feb 28, 2023Common Stock37,43037,430D

Explanation of responses